Results 31 to 40 of about 45,414 (227)
A survey of substance use for cognitive enhancement by university students in the Netherlands [PDF]
, 2015 Background: Pharmacological cognitive enhancement, using chemicals to change cellular processes in the brain in order to enhance one's cognitive capacities, is an often discussed phenomenon.
Bundt, Carsten +5 more
core +3 more sources
PLoS ONE, 2014 BackgroundCancer-related fatigue (CRF) is a common symptom affecting patients with cancer. There are an increasing number of trials examining potential treatments for CRF.
Shun Gong +7 more
doaj +1 more source
NeuroImage, 2022 Methylphenidate is a widely used first-line treatment for attention deficit/hyperactivity disorder (ADHD), but the underlying circuit mechanisms are poorly understood.
Yoshifumi Mizuno +6 more
doaj +1 more source
Post hoc analyses of the impact of previous medication on the efficacy of lisdexamfetamine dimesylate in the treatment of attention-deficit/hyperactivity disorder in a randomized, controlled trial [PDF]
, 2014 David R Coghill,1 Tobias Banaschewski,2 Michel Lecendreux,3 César Soutullo,4 Alessandro Zuddas,5 Ben Adeyi,6 Shaw Sorooshian7 1Division of Neuroscience, University of Dundee, Dundee, UK; 2Child and Adolescent Psychiatry and Psychotherapy, Central
Alessandro Alessandro Zuddas +7 more
core +6 more sources
Journal of Advanced Pharmaceutical Technology & Research, 2016 Attention-deficit hyperactivity disorder (ADHD) is a common psychiatric disorder among preschool children but the number of controlled clinical trials regarding psychopharmacological treatment in this age group is limited.
Parvin Safavi +2 more
doaj +1 more source
Conditioned place preference and locomotor activity in response to methylphenidate, amphetamine and cocaine in mice lacking dopamine D4 receptors [PDF]
, 2010 Methylphenidate (MP) and amphetamine (AMPH) are the most frequently prescribed medications for the treatment of attention-deficit/hyperactivity disorder (ADHD).
Bermeo, C. +6 more
core +1 more source
Journal of Central Nervous System Disease, 2010 Objective To review the literature on the safety and efficacy of methylphenidate, OROS-methylphenidate, methylphenidate ER, and dexmethylphenidate in adults with Attention-Deficit/Hyperactivity Disorder (ADHD).
Michael A. Sopko +2 more
doaj +1 more source
South African Family Practice, 2017 Background: The use of methylphenidate as cognitive enhancer is a growing trend among students at tertiary institutions globally. This study aimed to determine the prevalence of methylphenidate use and co-use with alcohol among on-campus residence ...
P M Van Zyl +7 more
doaj +1 more source
Characteristics of ADHD symptom response/remission in a clinical trial of methylphenidate extended release [PDF]
, 2019 Clinical trials in attention-deficit/hyperactivity disorder (ADHD) have typically measured outcome using clinician ratings on the Attention-Deficit/Hyperactivity Disorder Rating Scale, Fourth Edition (ADHD-RS-IV) and the Clinical Global Impression ...
Adjei, Akwete L +5 more
core +2 more sources
Non-medical use of methylphenidate among medical students of the University of the Free State
South African Journal of Psychiatry, 2017 Background: Faced with demanding training programmes, medical students may be more prone to use methylphenidate for non-medical purposes in order to improve concentration, alertness and academic performance.
Roshini Jain +5 more
doaj +1 more source